Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
about
The Challenge and Potential of Metagenomics in the ClinicInteractions Between the Gastrointestinal Microbiome and Clostridium difficileFecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and ObesityThe Hoops, Hopes, and Hypes of Human Microbiome ResearchHIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationProtective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model.Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.Clostridium difficile and the microbiotaProlonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.Being human is a gut feelingLow prevalence of Clostridium septicum fecal carriage in an adult population.Microbiota-mediated inflammation and antimicrobial defense in the intestine.Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.Humanized microbiota mice as a model of recurrent Clostridium difficile diseaseMicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis.The influence of non-steroidal anti-inflammatory drugs on the gut microbiomeFrom Hype to Hope: The Gut Microbiota in Enteric Infectious Disease.Proton pump inhibitors affect the gut microbiome.Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection.Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome.Hospitalization Type and Subsequent Severe SepsisLongitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home.Altered gut microbiota in female mice with persistent low body weights following removal of post-weaning chronic dietary restriction.Disruption of the microbiota across multiple body sites in critically ill childrenNLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth.Integrating Ecological and Engineering Concepts of Resilience in Microbial Communities.Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.Gut Microbiome and the Development of Food Allergy and Allergic DiseaseRegulation of Clostridium difficile spore germination by the CspA pseudoprotease domainImpact of demographics on human gut microbial diversity in a US Midwest populationTopological distortion and reorganized modular structure of gut microbial co-occurrence networks in inflammatory bowel diseaseIntricacies of assessing the human microbiome in epidemiologic studies.The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.Bacteriophage and their potential roles in the human oral cavity.Diarrhea after bariatric procedures: Diagnosis and therapy.Validation and Implementation of Clinical Laboratory Improvements Act-Compliant Whole-Genome Sequencing in the Public Health Microbiology Laboratory.
P2860
Q26766414-1FAF19E8-EFD4-417D-83F2-4C8D30B91AE9Q26778722-81839621-17A2-4A4C-92FA-C44EE9725A23Q28070349-C4E052B0-A732-4B72-9E35-A6FDE6215423Q28072111-D5F511EB-18FB-4FA3-8888-B11848603AA2Q30839904-65A49BE8-0B5F-4613-84A0-4CE2AC23EACFQ33586133-71DED050-4786-4726-BD35-312FF3A63F67Q34044442-0B2AA508-42B9-4AB6-8DF3-19D44D2F9AA1Q34311594-9D5A5747-FC1B-43AE-9F38-C1E89CB29B1BQ34566765-D04A7D1E-6670-4AD9-99F6-C075FF9BA3F9Q35176737-2CC9457F-7123-4730-A393-C93D1BFF39E5Q35269365-7462BD51-6698-4FAF-BE38-3350A4CA9EDBQ35541605-A1EC7B53-6A79-492F-B100-BEADF02E169EQ35689913-927A9082-0A21-431C-ADBC-BDF256702AD5Q35691177-AE9E18CD-276B-486D-ABDF-05CABC4F1EC5Q35750753-C33C77E0-E9AC-4BBD-A41C-28631DC9A6C3Q35803149-DD6E7242-71A5-4BC4-BD34-83419A364EECQ35813554-81DF8283-5B8D-4D2E-A603-6C49752A4F08Q35861517-B0C02F4E-65E8-4BCE-8BF4-9CD033AEED0AQ35866595-C45D9B5E-0E18-4EB6-8543-179B618E713FQ36001267-8E2B791D-9D70-49D6-AEA2-6D3F36CC8672Q36018079-4527BDDC-3470-4463-8970-ABE88080AC4AQ36018083-10C26B86-6892-4E06-B0B3-40D8F69DEA62Q36018176-20DF5944-0F48-497A-9746-C675EC5B6E5AQ36111061-5B4B2789-208A-4095-883D-62342FAD394CQ36128633-FA84727E-F348-4D9E-BADC-7F5A3DDFA26CQ36156866-18C30F90-1F01-4249-BEA5-BB0CF54528DEQ36157380-4E9F7FA5-8B73-4482-A258-A5B73D0A95A5Q36235947-A28E4C0F-91CA-463A-A3AF-855B26EE4962Q36306103-58F26380-7FF0-40FA-BD65-95AF5A22BBA0Q36332767-0DAFDE2B-CBDC-4AF0-9BC9-243CB86AFE68Q36370357-D309609B-DC22-48C8-84CC-85F77BEAEF7BQ36487279-91469248-DC44-4834-9A3C-301C0DB85907Q36520610-71C19286-A080-4A99-BAF8-D0FD3D0E8F29Q36525182-1AE18EE2-71CA-491F-8A14-596B5AA01C4EQ36910819-41F014F2-1387-4E9C-8244-07EB5F9947C3Q36968233-B0714508-2AD4-47ED-A2CD-A2AA1F057CA1Q36968334-2397886D-8CBB-4B67-BF92-ADDF203C5C67Q38415038-8CF78CDC-A212-4423-8045-44E891C5B7EFQ38648297-1B73FA33-86E4-46C5-8A67-16CA8E227039Q38737564-7583183F-10F4-4EFD-A61A-FD65B40D4144
P2860
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@ast
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@en
type
label
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@ast
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@en
prefLabel
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@ast
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@en
P2093
P2860
P921
P356
P1433
P1476
Microbiome data distinguish pa ...... iarrhea from healthy controls.
@en
P2093
Alyxandria M Schubert
Cathrin Ring
Jill Mogle
Joseph P Petrosino
Patrick D Schloss
Vincent B Young
P2860
P304
P356
10.1128/MBIO.01021-14
P577
2014-05-06T00:00:00Z